BioXcel Therapeutics, Inc.
BioXcel Therapeutics, Inc. (BTAI) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
btai · stock forecast · 15 analysts (3M) · FMP · updated Jun 9, 2026
Analyst Rating & Consensus
Based on 15 Wall Street analysts in the past 3 months
Buy
15 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$25.00
Consensus
$12.00
+986.0% upside
Low
$1.00
Median: $10 · Last Close: $1.10
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$12.00
986.0% upside
High Target
$25
2162.4%
Low Target
$1
-9.5%
Current Price
$1.10
as of today
Based on analyst price targets, the BTAI stock price prediction for the next 12 months ranges from $1 to $25. The consensus BTAI price forecast of $12.00 implies 986.0% upside from the current price of $1.10.
Short-Term Price Prediction
Low ActivityAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $1.10 | ↓ 0.66% |
1-day model range: $1.07–$1.12. Peak: $1.12 (-0.66%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · BTAI · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-04-02 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-05 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-09-15 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-09-12 | Mizuho | Maintains | Neutral→Neutral |
| 2025-08-28 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-08-19 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-08-15 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-07-15 | LUCID CAPITAL MARKETS | Maintains | Buy→Buy |
| 2025-06-23 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-01-30 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on BioXcel Therapeutics, Inc. (BTAI) stock. Of the recent 97 rating actions, 1 were upgrades and 7 were downgrades. 15 analysts currently cover BTAI.
Analyst Recommendation Trends
BTAI analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$2M
↓ 97.4% YoY
Revenue Next Year
$19M
↑ 1043.3% YoY
EPS This Year
$-1.67
EPS Next Year
$-1.53
↓ 8.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast BTAI EPS of $-1.67 for the current fiscal year, based on estimates from 1 analysts. The BTAI revenue forecast is $2M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The BTAI stock forecast is supported by two independent data sources: analyst consensus ratings from 15 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus BTAI price target is $12.00 (+986.0% upside), with an analyst consensus of Buy.
The BTAI short-term stock prediction for tomorrow is $1.10 (-0.66%).
BioXcel Therapeutics, Inc. trades on NASDAQ under the ticker BTAI. The BTAI stock outlook for 2027 is broadly positive, supported by a Buy consensus among 53% of covering analysts.
Frequently asked questions
BTAI forecast · 8 questionsAccording to 15 Wall Street analysts, the average 12-month BTAI price target is $12.00, with a high forecast of $25.00 and a low of $1.00. The median price target is shown in the chart above when available. This implies +986.0% potential upside from the current price of $1.10.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.